SPORTRADAR GROUP AG-A (SRAD) Fundamental Analysis & Valuation

NASDAQ:SRAD • CH1134239669

Current stock price

18.66 USD
-0.46 (-2.41%)
At close:
18.59 USD
-0.07 (-0.38%)
After Hours:

This SRAD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SRAD Profitability Analysis

1.1 Basic Checks

  • In the past year SRAD was profitable.
  • In the past year SRAD had a positive cash flow from operations.
  • SRAD had positive earnings in each of the past 5 years.
  • In the past 5 years SRAD always reported a positive cash flow from operatings.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • The Return On Assets of SRAD (3.49%) is comparable to the rest of the industry.
  • The Return On Equity of SRAD (10.25%) is better than 71.43% of its industry peers.
  • SRAD has a Return On Invested Capital (4.64%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SRAD is significantly below the industry average of 10.48%.
Industry RankSector Rank
ROA 3.49%
ROE 10.25%
ROIC 4.64%
ROA(3y)2.17%
ROA(5y)1.6%
ROE(3y)5.98%
ROE(5y)4.22%
ROIC(3y)4.69%
ROIC(5y)3.82%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of SRAD (7.78%) is better than 68.25% of its industry peers.
  • SRAD's Profit Margin has improved in the last couple of years.
  • SRAD has a Operating Margin (9.79%) which is comparable to the rest of the industry.
  • SRAD's Operating Margin has declined in the last couple of years.
  • SRAD has a Gross Margin of 77.73%. This is amongst the best in the industry. SRAD outperforms 90.48% of its industry peers.
  • SRAD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.79%
PM (TTM) 7.78%
GM 77.73%
OM growth 3Y40.27%
OM growth 5Y-5.57%
PM growth 3Y73.36%
PM growth 5Y15.68%
GM growth 3Y3.93%
GM growth 5Y1.8%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. SRAD Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRAD is destroying value.
  • The number of shares outstanding for SRAD remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for SRAD has been increased compared to 5 years ago.
  • Compared to 1 year ago, SRAD has a worse debt to assets ratio.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • SRAD has an Altman-Z score of 2.37. This is not the best score and indicates that SRAD is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.37, SRAD is in the better half of the industry, outperforming 65.87% of the companies in the same industry.
  • SRAD has a debt to FCF ratio of 0.36. This is a very positive value and a sign of high solvency as it would only need 0.36 years to pay back of all of its debts.
  • SRAD has a Debt to FCF ratio of 0.36. This is amongst the best in the industry. SRAD outperforms 91.27% of its industry peers.
  • SRAD has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • SRAD's Debt to Equity ratio of 0.05 is amongst the best of the industry. SRAD outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.36
Altman-Z 2.37
ROIC/WACC0.75
WACC6.2%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • SRAD has a Current Ratio of 1.17. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.17, SRAD perfoms like the industry average, outperforming 59.52% of the companies in the same industry.
  • SRAD has a Quick Ratio of 1.17. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
  • SRAD has a Quick ratio of 1.17. This is in the better half of the industry: SRAD outperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. SRAD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 272.73% over the past year.
  • SRAD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 44.42% yearly.
  • The Revenue has grown by 16.57% in the past year. This is quite good.
  • The Revenue has been growing by 26.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)272.73%
EPS 3Y108.86%
EPS 5Y44.42%
EPS Q2Q%483.33%
Revenue 1Y (TTM)16.57%
Revenue growth 3Y20.89%
Revenue growth 5Y26.08%
Sales Q2Q%20.13%

3.2 Future

  • SRAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.23% yearly.
  • SRAD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.29% yearly.
EPS Next Y21.57%
EPS Next 2Y36.98%
EPS Next 3Y27.23%
EPS Next 5YN/A
Revenue Next Year22.19%
Revenue Next 2Y18.57%
Revenue Next 3Y17.12%
Revenue Next 5Y13.29%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

3

4. SRAD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 39.70, SRAD can be considered very expensive at the moment.
  • SRAD's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, SRAD is valued quite expensively.
  • A Price/Forward Earnings ratio of 32.42 indicates a quite expensive valuation of SRAD.
  • The rest of the industry has a similar Price/Forward Earnings ratio as SRAD.
  • When comparing the Price/Forward Earnings ratio of SRAD to the average of the S&P500 Index (23.84), we can say SRAD is valued slightly more expensively.
Industry RankSector Rank
PE 39.7
Fwd PE 32.42
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SRAD is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
  • SRAD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.67
EV/EBITDA 10.03
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • SRAD has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as SRAD's earnings are expected to grow with 27.23% in the coming years.
PEG (NY)1.84
PEG (5Y)0.89
EPS Next 2Y36.98%
EPS Next 3Y27.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SRAD Dividend Analysis

5.1 Amount

  • SRAD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SRAD Fundamentals: All Metrics, Ratios and Statistics

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (3/13/2026, 8:00:00 PM)

After market: 18.59 -0.07 (-0.38%)

18.66

-0.46 (-2.41%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners91.91%
Inst Owner Change-1.59%
Ins Owners1.34%
Ins Owner ChangeN/A
Market Cap5.58B
Revenue(TTM)1.29B
Net Income(TTM)100.32M
Analysts82.86
Price Target31.9 (70.95%)
Short Float %5.54%
Short Ratio4.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.9%
Min EPS beat(2)-78.56%
Max EPS beat(2)-21.24%
EPS beat(4)2
Avg EPS beat(4)113.82%
Min EPS beat(4)-78.56%
Max EPS beat(4)413.81%
EPS beat(8)3
Avg EPS beat(8)54.21%
EPS beat(12)4
Avg EPS beat(12)30.64%
EPS beat(16)7
Avg EPS beat(16)8.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.47%
Min Revenue beat(2)-2.99%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.99%
Max Revenue beat(4)-0.42%
Revenue beat(8)4
Avg Revenue beat(8)1.19%
Revenue beat(12)4
Avg Revenue beat(12)-0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.37%
PT rev (1m)-1.95%
PT rev (3m)-3.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 39.7
Fwd PE 32.42
P/S 3.75
P/FCF 27.67
P/OCF 11.99
P/B 4.94
P/tB N/A
EV/EBITDA 10.03
EPS(TTM)0.47
EY2.52%
EPS(NY)0.58
Fwd EY3.08%
FCF(TTM)0.67
FCFY3.61%
OCF(TTM)1.56
OCFY8.34%
SpS4.98
BVpS3.78
TBVpS-4.08
PEG (NY)1.84
PEG (5Y)0.89
Graham Number6.32
Profitability
Industry RankSector Rank
ROA 3.49%
ROE 10.25%
ROCE 5.49%
ROIC 4.64%
ROICexc 5.52%
ROICexgc N/A
OM 9.79%
PM (TTM) 7.78%
GM 77.73%
FCFM 13.54%
ROA(3y)2.17%
ROA(5y)1.6%
ROE(3y)5.98%
ROE(5y)4.22%
ROIC(3y)4.69%
ROIC(5y)3.82%
ROICexc(3y)5.63%
ROICexc(5y)5.08%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.56%
ROCE(5y)4.52%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y28.03%
ROICexc growth 5Y-14.48%
OM growth 3Y40.27%
OM growth 5Y-5.57%
PM growth 3Y73.36%
PM growth 5Y15.68%
GM growth 3Y3.93%
GM growth 5Y1.8%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.36
Debt/EBITDA 0.11
Cap/Depr 67.75%
Cap/Sales 17.71%
Interest Coverage 1.48
Cash Conversion 86.97%
Profit Quality 174.06%
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 2.37
F-Score6
WACC6.2%
ROIC/WACC0.75
Cap/Depr(3y)80.11%
Cap/Depr(5y)85.9%
Cap/Sales(3y)20.37%
Cap/Sales(5y)21.33%
Profit Quality(3y)236.52%
Profit Quality(5y)154.22%
High Growth Momentum
Growth
EPS 1Y (TTM)272.73%
EPS 3Y108.86%
EPS 5Y44.42%
EPS Q2Q%483.33%
EPS Next Y21.57%
EPS Next 2Y36.98%
EPS Next 3Y27.23%
EPS Next 5YN/A
Revenue 1Y (TTM)16.57%
Revenue growth 3Y20.89%
Revenue growth 5Y26.08%
Sales Q2Q%20.13%
Revenue Next Year22.19%
Revenue Next 2Y18.57%
Revenue Next 3Y17.12%
Revenue Next 5Y13.29%
EBIT growth 1Y-6.15%
EBIT growth 3Y69.57%
EBIT growth 5Y19.05%
EBIT Next Year127.66%
EBIT Next 3Y51.79%
EBIT Next 5Y33.42%
FCF growth 1Y39.3%
FCF growth 3Y216.65%
FCF growth 5Y24.96%
OCF growth 1Y14.17%
OCF growth 3Y33.84%
OCF growth 5Y21.65%

SPORTRADAR GROUP AG-A / SRAD Fundamental Analysis FAQ

What is the fundamental rating for SRAD stock?

ChartMill assigns a fundamental rating of 6 / 10 to SRAD.


Can you provide the valuation status for SPORTRADAR GROUP AG-A?

ChartMill assigns a valuation rating of 3 / 10 to SPORTRADAR GROUP AG-A (SRAD). This can be considered as Overvalued.


How profitable is SPORTRADAR GROUP AG-A (SRAD) stock?

SPORTRADAR GROUP AG-A (SRAD) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SPORTRADAR GROUP AG-A (SRAD) stock?

The Price/Earnings (PE) ratio for SPORTRADAR GROUP AG-A (SRAD) is 39.7 and the Price/Book (PB) ratio is 4.94.


Can you provide the financial health for SRAD stock?

The financial health rating of SPORTRADAR GROUP AG-A (SRAD) is 6 / 10.